Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Respiratorius

1.35 SEK

+3.85 %

Less than 1K followers

RESP

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Respiratorius

2019202020212022202320242025
Revenue
growth-%
EBITDA-3.1-4.5-6.5-4.4-4.5-4.1-3.5
EBIT-5.1-7.1-9.6-6.0-7.8-7.5-7.0
Profit before taxes-5.1-7.5-9.6-6.3-7.8-7.6-7.0
Net income-5.1-7.5-9.6-6.3-7.8-7.6-7.0
EPS-2.77-3.47-3.94-1.83-2.75-1.89-1.17
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%
EBIT-%
ROE-31.5 %-25.5 %-17.0 %-18.3 %-29.5 %-25.1 %-22.7 %
ROI-28.4 %-24.2 %-15.5 %-17.6 %-28.1 %-24.4 %-21.8 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.